Insiders Jazz Pharmaceuticals plc

Equities

JAZZ

IE00B4Q5ZN47

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 03:58:31 2025-12-15 pm EST			5-day change	1st Jan Change
169.25 ^USD	+1.04%		+0.46%	+37.82%

Dec. 11	Jazz Pharmaceuticals Insider Sold Shares Worth $379,366, According to a Recent SEC Filing	MT
Dec. 10	This Is Decision Day

Insiders

Jazz Pharmaceuticals Insider Sold Shares Worth $379,366, According to a Recent SEC Filing	Dec. 11	MT
Jazz Pharmaceuticals Insider Sold Shares Worth $797,783, According to a Recent SEC Filing	Dec. 09	MT
Jazz Pharmaceuticals Insider Sold Shares Worth $13,780,337, According to a Recent SEC Filing	Dec. 02	MT
Jazz Pharmaceuticals Insider Sold Shares Worth $607,127, According to a Recent SEC Filing	Nov. 24	MT
Jazz Pharmaceuticals Insider Sold Shares Worth $3,259,538, According to a Recent SEC Filing	Nov. 21	MT
Jazz Pharmaceuticals Insider Sold Shares Worth $1,204,573, According to a Recent SEC Filing	Nov. 20	MT
Immix Biopharma, Inc. Appoints Michael Grabow as Chief Commercial Officer	Nov. 12	CI
Jazz Pharmaceuticals plc Announces Board Changes, Effective December 1, 2025	Oct. 28	CI
Ionis, Jazz Named Top Picks as US Biopharma Heads Into Steady Q3, BofA Says	Oct. 09	MT
Crane NXT, Co. Announces Appointment of Kim Dimaurizio as Senior Vice President and Chief People Officer, Effective October 1, 2025	Oct. 01	CI
Jazz Pharmaceuticals Insider Sold Shares Worth $771,690, According to a Recent SEC Filing	Sep. 04	MT
Jazz Pharmaceuticals Renee Gala named as president and CEO effective August 11 - SEC filing	Aug. 05	RE
Compass Pathways plc Announces Board Changes	Jul. 29	CI
Lantern Pharma Inc. Announces Appointment of Lee Schalop to Board of Directors	Jul. 28	CI
Jazz Pharmaceuticals plc Announces President Changes, Effective August 11, 2025	Jul. 10	CI
Jazz Pharmaceuticals plc Announces Chief Executive Officer Changes, Effective August 11, 2025	Jul. 10	CI
Jazz Pharmaceuticals Names Renee Gala Chief Executive	Jul. 10	MT
Appeals Court Affirms Favorable FDA Ruling for Avadel in Lumryn Litigation	Jun. 30	DJ
Jazz Pharmaceuticals Insider Bought Shares Worth $9,993,082, According to a Recent SEC Filing	May. 14	MT
Akari Therapeutics Names Abizer Gaslightwala CEO	Mar. 20	MT
Akari Therapeutics, Plc Announces Chief Executive Officer Changes	Mar. 20	CI
Mindmed Appoints Matt Wiley as Chief Commercial Officer	Mar. 17	CI
Jazz Pharmaceuticals Insider Sold Shares Worth $332,605, According to a Recent SEC Filing	Mar. 12	MT
DexCom, Inc. Appoints Renée Galá as A Director	Mar. 10	CI
Akari Therapeutics, plc Announces Board Changes	Dec. 18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Jazz Pharmaceuticals plc

Equities

JAZZ

IE00B4Q5ZN47

Pharmaceuticals

Insiders

Filters